WASHINGTON, D.C. | April 24, 2023
Unfortunately, the threat facing patients continues as the case of Alliance for Hippocratic Medicine et al. v FDA et al. has been sent back to the lower court. The litigation jeopardizes access to FDA-approved medications and other treatments by shifting decisions about drug safety to judges. For the time being, however, patients will continue to have access to mifepristone and other FDA-approved drugs and treatments without court-imposed limitations.
Generations of Americans have trusted the FDA’s expertise which, over time, has yielded rigorous, science- and data-based approval of tens of thousands of lifesaving and life-changing medications for people with acute or chronic serious health conditions. Experts in science and medicine are best equipped to determine the safety and efficacy of drugs and treatments, and it is dangerous to eviscerate or dilute their authority.
We strongly support the FDA's role in safeguarding patients and urge the Fifth Circuit Court of Appeals to reverse the U.S. District Court’s decision.
American Cancer Society Cancer Action Network
American Childhood Cancer Organization
American Kidney Fund
American Lung Association
American Society of Hematology
Association for Clinical Oncology
Asthma and Allergy Foundation of America
Cancer Support Community
Chronic Disease Coalition
Crohn's & Colitis Foundation
Cystic Fibrosis Foundation
EveryLife Foundation for Rare Diseases
Friends of Cancer Research
Hemophilia Federation of America
Infusion Access Foundation
Lupus Foundation of America
National Coalition for Cancer Survivorship
National Health Council
National Multiple Sclerosis Society
National Organization for Rare Disorders
National Patient Advocate Foundation
National Psoriasis Foundation
Pulmonary Hypertension Association
RESOLVE: The National Infertility Association
Susan G. Komen
The Leukemia & Lymphoma Society
The Mended Hearts, Inc.
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
We Need Your Help
Make a donation that will save lives. Because when you can't breathe, nothing else matters.